CoChat

Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study

Open access
Dimou, Niki L, Papadimitriou, Nikos, Gill, Dipender, Christakoudi, Sofia, Murphy, Neil, Gunter, Marc J, Travis, Ruth C, Key, Tim J, Fortner, Renee T, Haycock, Philip C, Lewis, Sarah J, Muir, Kenneth, Martin, Richard M, Tsilidis, Konstantinos K · 2019 · International Journal of Epidemiology
Cited by 78

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Background: There are observational data suggesting an inverse association between circulating concentrations of sex hormone binding globulin (SHBG) and risk of postmenopausal breast cancer. However, causality is uncertain and few studies have investigated this association by tumour receptor status. We aimed to investigate these associations under the causal framework of Mendelian randomization (MR). Methods: We used summary association estimates extracted from published genome-wide association study (GWAS) meta-analyses for SHBG and breast cancer, to perform two-sample MR analyses. Summary statistics were available for 122 977 overall breast cancer cases, of which 69 501 were estrogen receptor positive (ER+ve) and 21 468 were ER-ve, and 105 974 controls. To control for potential horizontal pleiotropy acting via body mass index (BMI), we performed multivariable inverse-variance weighted (IVW) MR as the main analysis, with the robustness of this approach further tested in sensitivity analyses. Results: The multivariable IVW MR analysis indicated a lower risk of overall (odds ratio [OR]: 0.94; 95% confidence interval [CI]: 0.90, 0.98; P: 0.006) and ER+ve (OR: 0.92; 95% CI: 0.87, 0.97; P: 0.003) breast cancer, and a higher risk of ER-ve disease (OR: 1.09; 95% CI: 1.00, 1.18; P: 0.047) per 25 nmol/L higher SHBG levels. Sensitivity analyses were consistent with the findings of the main analysis. Conclusions: We corroborated the previous literature evidence coming from observational studies for a potentially causal inverse association between SHBG concentrations and risk of ER+ve breast cancer, but our findings also suggested a potential novel positive association with ER-ve disease that warrants further investigation, given the low prior probability of being true.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyz107

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Metadata

Authors
Dimou, N. L., Papadimitriou, N., Gill, D., Christakoudi, S., Murphy, N., Gunter, M. J., Travis, R. C., Key, T. J., Fortner, R. T., Haycock, P. C., Lewis, S. J., Muir, K., Martin, R. M., & Tsilidis, K. K.
Venue
International Journal of Epidemiology
Published
2019-05-29
Volume
48
Issue
3
Pages
807-816
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2947726802
Cited by
78
References
22
FWCI
4.60
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study. https://app.cochat.ai/papers/10.1093/ije/dyz107
The paper
Dimou, N. L., Papadimitriou, N., Gill, D., Christakoudi, S., Murphy, N., Gunter, M. J., Travis, R. C., Key, T. J., Fortner, R. T., Haycock, P. C., Lewis, S. J., Muir, K., Martin, R. M., & Tsilidis, K. K. (2019). Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyz107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.